Linjardy 5/25mg Tablet
₨ 742
About this product
Overview
Linjardy 5/25mg Tablet is a combination medication containing two active ingredients: Empagliflozin & Linagliptin. It is prescribed for the management of type 2 diabetes mellitus in adults to help control blood sugar levels.
Key Ingredients
- Empagliflozin: Empagliflozin belongs to a class of medications known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works by helping the kidneys remove glucose from the bloodstream through the urine, thereby lowering blood sugar levels.
- Linagliptin: Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of incretin hormones in the body, which stimulate the pancreas to produce more insulin and reduce the amount of glucose produced by the liver.
Uses
- Type 2 Diabetes: Linjardy 5/25mg Tablet is used to improve glycemic control in adults with type 2 diabetes mellitus. It helps lower blood sugar levels by two different mechanisms, enhancing insulin secretion and reducing glucose reabsorption in the kidneys.
Administration
- Linjardy 5/25mg Tablet is typically taken orally, once daily, with or without food, as directed by a healthcare professional.
- The dosage may vary depending on individual patient factors such as kidney function, response to treatment, and other medications being taken for diabetes management.
- It is essential to follow the prescribed regimen provided by the healthcare provider to achieve optimal glycemic control and reduce the risk of complications associated with diabetes.
Precautions
- Before starting treatment with Linjardy 5/25mg Tablet, inform your healthcare provider about any existing medical conditions, especially kidney problems or a history of diabetic ketoacidosis.
- Inform your healthcare provider about all medications, supplements, and herbal products you are currently taking, as they may interact with Empagliflozin and Linagliptin.
- Monitor blood sugar levels regularly as directed by your healthcare provider while taking Linjardy 5/25mg Tablet to ensure effective glycemic control.
- Report any signs of adverse effects such as urinary tract infections, genital yeast infections, or symptoms of hypoglycemia (low blood sugar) to your healthcare provider promptly.
Linjardy 5/25mg Tablet combines the complementary actions of Empagliflozin and Linagliptin to effectively manage blood sugar levels in adults with type 2 diabetes mellitus. By targeting multiple pathways involved in glucose regulation, it offers a comprehensive approach to diabetes management.
This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.
Other brands of EMPAGLIFLOZIN + Linagliptin
These medicines also contain EMPAGLIFLOZIN + Linagliptin, but in a different strength or pack. Do not switch to a different strength without asking your doctor.
| Medicine | Manufacturer | Strength | Price |
|---|---|---|---|
| Linjardy 5/10mg Tablet | CCL Pharmaceuticals PTV AL Qamar | 5/10mg | Rs 527.80 |
Customer reviews
You must be logged in to post a review.




Reviews
Clear filtersThere are no reviews yet.